Get the Stockscreener App
1.65
0.00%
0.00
Geron Corp stock is traded at $1.65, with a volume of 16.13M.
It is up +0.00% in the last 24 hours and down -5.17% over the past month.
See More
Previous Close:
$1.65
Open:
$1.65
24h Volume:
16.13M
Relative Volume:
1.10
Market Cap:
$1.05B
Revenue:
$29.48M
Net Income/Loss:
$-201.19M
P/E Ratio:
-5.1563
EPS:
-0.32
Net Cash Flow:
$-216.50M
1W Performance:
-9.34%
1M Performance:
-5.17%
6M Performance:
-63.89%
1Y Performance:
-50.00%
1-Day Range:
$1.60
$1.66
1-Week Range:
$1.60
$1.8299
52-Week Range:
$1.4601
$5.34
Geron Corp Stock (GERN) Company Profile
Name
Geron Corp
Sector
Industry
Phone
(650) 473-7700
Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.65 | 1.05B | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Feb-26-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Initiated | H.C. Wainwright | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-09-24 | Initiated | Leerink Partners | Outperform |
| Apr-30-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-29-24 | Initiated | TD Cowen | Buy |
| Mar-15-24 | Reiterated | Needham | Buy |
| Sep-12-23 | Upgrade | Goldman | Neutral → Buy |
| Mar-28-23 | Initiated | Goldman | Neutral |
| Oct-28-22 | Initiated | Wedbush | Outperform |
| Jul-28-22 | Resumed | B. Riley Securities | Buy |
| Nov-02-21 | Initiated | Robert W. Baird | Outperform |
| Feb-18-21 | Resumed | B. Riley Securities | Buy |
| Aug-03-20 | Initiated | Stifel | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Sep-03-19 | Initiated | H.C. Wainwright | Buy |
| Aug-15-19 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-09-19 | Upgrade | Needham | Hold → Buy |
| Jan-31-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Oct-02-18 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-05-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Sep-13-16 | Reiterated | FBR & Co. | Outperform |
| Sep-13-16 | Reiterated | FBR Capital | Outperform |
| Dec-07-15 | Reiterated | Piper Jaffray | Overweight |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Jun-12-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-12-14 | Downgrade | MLV & Co | Buy → Hold |
| Dec-10-13 | Reiterated | MLV & Co | Buy |
| Dec-10-13 | Upgrade | Needham | Hold → Buy |
| Nov-08-13 | Reiterated | MLV & Co | Buy |
| Oct-16-13 | Initiated | MLV & Co | Buy |
| Aug-30-12 | Initiated | Stifel Nicolaus | Buy |
| Jun-28-12 | Initiated | Needham | Hold |
View All
Geron Corp Stock (GERN) Latest News
GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights - PR Newswire
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)? - Yahoo Finance
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit - Marketscreener.com
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
GERN Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)Contact Kessler Topaz Meltzer & Check, LLP - Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XPLR, Geron, enCore, and TFI and Encourages Investors to Contact the Firm - TradingView
Deep Track Capital, LP's Strategic Acquisition of Geron Corp Shares - GuruFocus.com
Is Geron Corporation (NASDAQ:GERN) The Top Penny Stock That Will Skyrocket? - Yahoo Finance
Top 10 Penny Stocks That Will Skyrocket - Insider Monkey
GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN - GlobeNewswire Inc.
Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Eastern Progress Online
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Indo-Asian News Service - IANS India Pvt Ltd
Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025GERN - PR Newswire
Geron Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 12, 2025 to Discuss Your RightsGERN - PR Newswire
Geron reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 19, 2025 at 04:43 pm EDT - Marketscreener.com
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey
Geron Corp: How Concerned Should We Be About Rytelo Sales? (NASDAQ:GERN) - Seeking Alpha
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - Markets Insider
10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey
Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
GERN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Geron Corporation Investors - TradingView
GERN INVESTOR ALERT: Geron Corporation Investors with Substantia - GuruFocus.com
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
HC Wainwright Reiterates Neutral Rating for Geron (NASDAQ:GERN) - Defense World
GERN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Investor Brings Securities Class Action Against Geron Corp. (1) - Bloomberg Tax
SBI Securities Co. Ltd. Acquires New Holdings in Geron Co. (NASDAQ:GERN) - Defense World
Geron’s SWOT analysis: biotech stock faces pivotal year for growth By Investing.com - Investing.com South Africa
Geron Corp appoints interim CEO amid leadership shuffle By Investing.com - Investing.com Australia
Geron Corp reveals CEO is leaving - The Pharma Letter
H.C. Wainwright holds neutral on Geron stock post-EU approval - Investing.com
H.C. Wainwright holds neutral on Geron stock post-EU approval By Investing.com - Investing.com South Africa
Geron’s SWOT analysis: biotech stock faces pivotal year for growth - Investing.com
Geron Co. (NASDAQ:GERN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Longtime Bay Area biotech CEO abruptly steps down - The Business Journals
Geron Announces Leadership Change with New Interim CEO - TipRanks
Geron Corp appoints interim CEO amid leadership shuffle - Investing.com India
Geron’s RYTELO gains EC approval for certain blood cancers - Investing.com
Geron announces EC approval of Rytelo - TipRanks
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS - Yahoo Finance
Geron announces leadership transition, focuses on cancer drug potential - Investing.com
Geron CEO Scarlett to leave company - TipRanks
Geron Corporation Announces Departure Of CEO -March 11, 2025 at 04:03 pm EDT - Marketscreener.com
Geron Reshapes Leadership After FDA Win: CEO Exits as RYTELO Launch Takes Center Stage - StockTitan
Geron Corp Stock (GERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geron Corp Stock (GERN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SCARLETT JOHN A | Chairman, President and CEO |
Feb 27 '25 |
Buy |
1.76 |
12,500 |
22,062 |
12,500 |
| Ziegler James | EVP, Chief Commercial Officer |
Feb 27 '25 |
Buy |
1.60 |
100,000 |
160,000 |
100,000 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer |
Jul 08 '24 |
Option Exercise |
1.72 |
674,348 |
1,159,879 |
674,348 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer |
Jul 08 '24 |
Sale |
4.56 |
674,348 |
3,073,004 |
0 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Option Exercise |
1.19 |
287,900 |
341,693 |
155,400 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Sale |
4.63 |
287,900 |
1,334,129 |
0 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Option Exercise |
1.06 |
421,875 |
447,188 |
421,875 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Sale |
4.64 |
421,875 |
1,959,609 |
0 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Option Exercise |
2.54 |
600,000 |
1,524,000 |
600,000 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Sale |
4.00 |
600,000 |
2,400,000 |
600,000 |
0.39%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):